Drug manufacturers will have few alternatives in negotiating Medicare rates

Drug manufacturers will have few alternatives in negotiating Medicare rates

The Inflation Reduction Act gives the U.S. Department of Health and Human Services the authority to negotiate the cost of some prescription drugs covered under Medicare Part D. But although it’s called negotiation, drug manufacturers may find themselves at a distinct disadvantage if they don’t agree with HHS.